title: The enigma of conditioned taste aversion learning: stimulus properties of 2-phenylethylamine derivatives.
abstract: The functional aversive stimulus properties of several IP doses of (+/-)-amphetamine (1.25-10 mg.kg-1), 2-phenylethylamine (PEA, 2.5-10 mg.kg-1, following inhibition of monoamine oxidase with pargyline 50 mg.kg-1) and phenylethanolamine (6.25-50 mg.kg-1) were measured with the conditioned taste aversion (CTA) paradigm. A two-bottle choice procedure was used, water vs. 0.1 % saccharin with one conditioning trial and three retention trials. (+/-)-Amphetamine and phenylethanolamine induced a significant conditioned taste aversion but PEA did not. (+/-)-Amphetamine and PEA increased spontaneous locomotor activity but phenylethanolamine had no effects on this measure. Measurement of whole brain levels of these drugs revealed that the peak brain elevation of PEA occurred at approximately 10 min whereas the peak elevations of (+/-)-amphetamine and phenylethanolamine occurred at approximately 20 min. The present failure of PEA to elicit conditioned taste aversion learning is consistent with previous reports for this compound. The differential functional aversive stimulus effects of these three compounds are surprising since they exhibit similar discriminative stimulus properties and both (+/-)-amphetamine and PEA are self-administered by laboratory animals. The present data suggest that time to maximal brain concentrations following peripheral injection may be a determinant of the aversive stimulus properties of PEA derivatives.
authors.affiliation: Neurochemical Research Unit, Department of Psychiatry, University of Alberta, Edmonton, Canada. andy.greenshaw@ualberta.ca
authors.forename: A J
authors.initials: AJ
authors.lastname: Greenshaw
authors.forename: S
authors.initials: S
authors.lastname: Turrkish
authors.forename: B A
authors.initials: BA
authors.lastname: Davis
mesh_terms: D000661:Amphetamine / Q000493:pharmacokinetics / Q000494:pharmacology; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D001921:Brain / Q000378:metabolism; D003213:Conditioning, Psychological / Q000187:drug effects*; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009994:Osmolar Concentration; D010627:Phenethylamines / Q000493:pharmacokinetics / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013649:Taste; D013997:Time Factors
chemical_list: D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D000661:Amphetamine